Q2 2012 Results (Alnylam) - Aug 6, 2012 - "Rapid, dose-dependent, and durable knockdown of PCSK9 of up to 84% with mean lowering of 68% at 0.4 mg/kg group (p<0.0001); Major reductions in LDL-C of up to 50% with mean lowering of 41% at 0.4 mg/kg group (p<0.01)"
P1 data • Dyslipidemia
|